Litcius/Paper detail

A peptide-based subunit candidate vaccine against SARS-CoV-2 delivered by biodegradable mesoporous silica nanoparticles induced high humoral and cellular immunity in mice

Lei Qiao, Minmin Chen, Suyan Li, Jinxia Hu, Chaoju Gong, Zhuoqi Zhang, Xichuan Cao

2021Biomaterials Science18 citationsDOI

Abstract

, could efficiently deliver epitope peptides into the cytoplasm of RAW264.7 cells. Strong Th1-biased humoral and cellular immunity were induced by B/T@BMSNs in mice and all the 10 selected epitopes were identified as effective antigen epitopes, which could induce robust peptide-specific immune response. The elicited functional antibody could bind to the recombinant S protein and block the binding of the S protein to the ACE-2 receptor. These results demonstrate the potential of a nanoparticles vaccine platform based on BMSNs to rapidly develop peptide-based subunit vaccine candidates against SARS-CoV-2.

Topics & Concepts

EpitopePeptidePeptide vaccineProtein subunitImmune systemAntigenHumoral immunityChemistryAntibodyVirologyImmunityBiologyBiochemistryImmunologyGeneImmunotherapy and Immune Responsesvaccines and immunoinformatics approachesSARS-CoV-2 and COVID-19 Research
A peptide-based subunit candidate vaccine against SARS-CoV-2 delivered by biodegradable mesoporous silica nanoparticles induced high humoral and cellular immunity in mice | Litcius